Bruno Montanari is a Partner at Seroba, which he joined in 2017, and is based in continental Europe. He was previously a Partner at Omnes Capital in Paris, where he ran life sciences investments for the venture capital team, and before that worked in venture capital at Atlas Venture in Paris and London and at CDP Capital in Paris and Montreal. He began his career in 1999 in London in the healthcare teams of Deutsche Bank and later Merrill Lynch. He sits on the board of Coave Therapeutics and holds board observer roles at Sibylla Biotech, Vico Therapeutics, Artica Therapeutics, Azafaros and Alveus Therapeutics.
Education
PharmD, Université René Descartes, Paris V
Master's degree in Strategic Management, HEC
Previous Experience
Partner, Omnes Capital
Atlas Venture
CDP Capital
Deutsche Bank - investment banking, healthcare team
Merrill Lynch - investment banking, healthcare team